NYSE-Deutsche Continue to Allure EU - Analyst Blog
December 14 2011 - 1:31PM
Zacks
Yesterday, Reuters reported that NYSE Euronext
Inc.’s (NYX) proposed $9 billion merger with
Frankfurt-based Deutsche Boerse has now decided to dispose of
NYSE’s Liffe, its exchange-traded derivative business, in order to
shove off the European Union Commission’s (EUC) antitrust concerns
over the deal.
Since both the parties agreed to merge in February this year,
the EUC began its multi-phase intense review and fears that the
merger provides ample scope for a monopolistic model in future,
primarily with the fusion of NYSE Liffe and Deutsche Boerse’s Eurex
derivative markets. According to the Federation of European
Securities Exchanges, Eurex and Liffe have accounted for 97% of
European stock futures trading and 93.7% of stock options trading
so far in 2011.
In October this year, the EUC also clarified that it would
identify exchange-listed derivatives market as the pertinent
product market and not the over-the-counter (OTC) derivatives. On
the flip side, the merger parties have also made a
counter-explanation regarding the EUC concern over the loss of
competition in the derivative market from the proposed merger.
Both NYSE and Deutsche Boerse are trying to explain the
difference in their mode of operations, related to both the product
and geographic scopes that primarily define the law of competition
in any industry. The parties-to-merger have also claimed that
majority of their derivative markets are traded as part of the OTC
market and not through an exchange, thereby leaving ample room for
healthy competition in the European markets.
Meanwhile, the German local authorities are closely scrutinizing
the merger deal.Earlier this week, this regulator raised some
objections over the effect of the combined entity’s future
operations in Frankfurt. However, a reply from the exchange
operators remains pending.
Hence, NYSE and Deutsche Boerse have now proffered to divest
some more of their equity derivatives trading operations, which
includes the divestment of NYSE Liffe in their home markets.
Additionally, both the parties are also ready to open up Deutsche
Boerse’s Eurex Clearing – clearinghouse for derivatives products –
to outsiders including its arch rivals for some products. Besides,
the parties-to-merger have also agreed upon licensing Eurex trading
to third parties, who are interested in initiating interest rate
swaps on this platform.
Solid Stock Exchange Ever
The NYSE-Deutsche merger is expected to be the most solid
business combination in the history of the global stock exchanges.
Based on 2010 net revenues, the prospective merger will earn
approximately 37% of total revenue from derivatives trading &
clearing, 29% in cash listings, trading & clearing, 20% in
settlement & custody and 14% in market data, index &
technology services.
Moreover, the prospective merger is expected to generate full
run-rate cost synergies of €400 million ($580 million) along with
€150 million ($218 million) in revenue synergies.
However, the EUC had already made it very clear in March this
year that the deal could undergo a delay on grounds of regulatory
impediments arising out of extensive reviewing. As a result of the
ongoing extensive probe in Europe, the EUC is now expected to bring
out its report card by February 9, 2012, postponing it from the
previous deadline, which expired yesterday. Upon the successful
outcome of the review, the deal is now projected to be sealed by
early next year.
Industry Moves
While a roar of merger and acquisition activities were witnessed
in the past three quarters, most of them never saw light due to the
regulatory snags, echoing the paramount importance of the
regulatory processes. The London Stock Exchange failed to take over
Canada’s TMX Group and the Singapore Stock Exchange was also unable
to acquire the Australian Stock Exchange owing to opposition from
regulatory authorities in both the countries.
Even NASDAQ OMX Group Inc. (NDAQ) and
IntercontinentalExchange Inc.’s (ICE)
premium-priced joint takeover bid was repeatedly rejected by NYSE
on account of multiple antitrust issues.
However, the NYSE-Deutsche merger has been strategically and
successfully crossing hurdles in the US, another merger that
appears to have survived is the one between BATS Global Markets
Inc. and Chi-X Europe. This is soon expected to merge in a deal
that will bring in a significant new competitor in European equity
trading.
INTERCONTINENTL (ICE): Free Stock Analysis Report
NASDAQ OMX GRP (NDAQ): Free Stock Analysis Report
NYSE EURONEXT (NYX): Free Stock Analysis Report
Zacks Investment Research
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From May 2024 to Jun 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Jun 2023 to Jun 2024